Author

H.-J. Jang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Burt· 1 shared C. Y. Truong· 1 shared D. Ramos· 1 shared D. Y. Wang· 1 shared E. M. Lo· 1 shared H. M. Holmes· 1 shared H.-S. Lee· 1 shared J.-S. Lee· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

B. Burt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of CDK4/6 Overcomes Primary Resistance to PD-1 Blockade in Malignant Mesothelioma

H.-J. Jang, C. Y. Truong, E. M. Lo, H. M. Holmes, D. Ramos, M. Ramineni, J.-S. Lee, D. Y. Wang, M. Pietropaolo, R. T. Ripley, B. Burt, H.-S. Lee

This study identifies CDK4/6 as a therapeutic target to overcome primary resistance to PD-1 blockade in malignant mesothelioma by analyzing genomic and immunogenomic data.

bioRxiv · Mar 4, 2021Immunology